No shared counterparties.
| Stage | TXN | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.1B | 100.00% | $96.2B | 100.00% | NVDA ×15.89 |
| Gross profit | $3.9B | 64.19% | $72.1B | 74.98% | NVDA +10.8pp |
| Operating income | $2.9B | 47.46% | $63.7B | 66.24% | NVDA +18.8pp |
| Pre-tax income | $2.8B | 46.33% | $71.5B | 74.32% | NVDA +28.0pp |
| Net income | $2.4B | 40.05% | $59.7B | 62.03% | NVDA +22.0pp |
| Stage | TXN | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $6.1B100.00% | $96.2B100.00% | NVDA ×15.89 |
| Gross profit | 64.19%$3.9B | 74.98%$72.1B | NVDA +10.8pp |
| Operating income | 47.46%$2.9B | 66.24%$63.7B | NVDA +18.8pp |
| Pre-tax income | 46.33%$2.8B | 74.32%$71.5B | NVDA +28.0pp |
| Net income | 40.05%$2.4B | 62.03%$59.7B | NVDA +22.0pp |